Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edgewise Therapeutics Inc
(NQ:
EWTX
)
30.79
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
30.79
Bid (Size)
30.79 (4)
Ask (Size)
30.80 (10)
Prev. Close
30.79
Today's Range
30.79 - 30.79
52wk Range
5.930 - 38.12
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 07, 2024
From
Edgewise Therapeutics
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
October 16, 2024
Via
Benzinga
Performance
YTD
+179.91%
+179.91%
1 Month
-11.65%
-11.65%
3 Month
+63.60%
+63.60%
6 Month
+64.04%
+64.04%
1 Year
+378.85%
+378.85%
More News
Read More
Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
October 01, 2024
From
Edgewise Therapeutics
Via
Business Wire
MarketBeat Week in Review – 9/23 - 9/27
September 28, 2024
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Analysts Think There's Still Time to Get in on Edgewise, Up 332%
September 25, 2024
Via
MarketBeat
Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Crude Oil Gains Over 1%; Mobileye Global Shares Jump
September 19, 2024
Via
Benzinga
Exposures
Fossil Fuels
Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
September 19, 2024
Via
MarketBeat
Why Edgewise Therapeutics Stock Is Up 50% on Thursday
September 19, 2024
Via
The Motley Fool
Dow Jumps Over 500 Points; FactSet Research Posts Upbeat Earnings
September 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Edgewise Therapeutics Stock Shoots Higher On Promising Early Results For Thickened Heart Treatment
September 19, 2024
Via
Benzinga
Darden Restaurants Posts Q1 Results, Joins Tesla, Nvidia, XPeng And Other Big Stocks Moving Higher On Thursday
September 19, 2024
Via
Benzinga
Edgewise Catapults On Surprise Victory In Cardiomyopathy; Cytokinetics Shares Dip
September 19, 2024
Via
Investor's Business Daily
Edgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM)
September 19, 2024
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Data from Phase 1 trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM) on Thursday, September 19 at 8:30 am Eastern Time
September 17, 2024
From
Edgewise Therapeutics
Via
Business Wire
EWTX Stock Earnings: Edgewise Therapeutics Beats EPS for Q2 2024
August 08, 2024
Via
InvestorPlace
Edgewise Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 08, 2024
From
Edgewise Therapeutics
Via
Business Wire
7 Small-Cap Stocks to Buy for Large-Scale Gains
July 30, 2024
Via
InvestorPlace
Stock Market News For July 23: Quick Takes On GE Aerospace, Boeing, Biotechs
July 23, 2024
Via
Investor's Business Daily
Topics
Government
Exposures
Political
Biogen Has Up To $10 Billion For Acquisitions; Why These Three Names Make Sense
July 16, 2024
Via
Investor's Business Daily
Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day
May 13, 2024
Via
Investor's Business Daily
Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024
May 10, 2024
From
Edgewise Therapeutics
Via
Business Wire
EWTX Stock Earnings: Edgewise Therapeutics Beats EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
May 09, 2024
Via
Benzinga
Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 09, 2024
From
Edgewise Therapeutics
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.